Selected research
Market Structure
Global Formula DHA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Formula DHA market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Formula DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Formula DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Formula DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Formula DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Formula DHA include DSM, Roquette, ADM, Corbion, Lonza Group, CABIO, Fuxing, Runke and Cellana, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Formula DHA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Formula DHA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Formula DHA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Formula DHA market size, projected growth trends, production technologies, key applications, and end-use industries.
Formula DHA Segment by Company
DSM
Roquette
ADM
Corbion
Lonza Group
CABIO
Fuxing
Runke
Cellana
JC Biotech
Yuexiang
FEMICO
Huison
Qingdao Keyuan
Formula DHA Segment by Type
Natural
Concentrated
Formula DHA Segment by Application
Adult Formula
Infant Formula
Formula DHA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formula DHA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Formula DHA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formula DHA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Formula DHA market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Formula DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Formula DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Formula DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Natural
- Concentrated
Applications
- Adult Formula
- Infant Formula
Companies covered
- DSM
- Roquette
- ADM
- Corbion
- Lonza Group
- CABIO
- Fuxing
- Runke
- Cellana
- JC Biotech
- Yuexiang
- FEMICO
- Huison
- Qingdao Keyuan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Formula DHA Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Formula DHA Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Formula DHA Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Formula DHA Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Formula DHA Market Dynamics
- 2.1 Formula DHA Industry Trends
- 2.2 Formula DHA Industry Drivers
- 2.3 Formula DHA Industry Opportunities and Challenges
- 2.4 Formula DHA Industry Restraints
3 Formula DHA Market by Manufacturers
- 3.1 Global Formula DHA Revenue by Manufacturers (2021-2026)
- 3.2 Global Formula DHA Sales by Manufacturers (2021-2026)
- 3.3 Global Formula DHA Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Formula DHA Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Formula DHA Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Formula DHA Manufacturers, Product Type & Application
- 3.7 Global Formula DHA Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Formula DHA Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Formula DHA Players Market Share by Revenue in 2025
- 3.8.3 2025 Formula DHA Tier 1, Tier 2, and Tier 3
4 Formula DHA Market by Type
- 4.1 Formula DHA Type Introduction
- 4.1.1 Natural
- 4.1.2 Concentrated
- 4.2 Global Formula DHA Sales by Type
- 4.2.1 Global Formula DHA Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Formula DHA Sales by Type (2021-2032)
- 4.2.3 Global Formula DHA Sales Market Share by Type (2021-2032)
- 4.3 Global Formula DHA Revenue by Type
- 4.3.1 Global Formula DHA Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Formula DHA Revenue by Type (2021-2032)
- 4.3.3 Global Formula DHA Revenue Market Share by Type (2021-2032)
5 Formula DHA Market by Application
- 5.1 Formula DHA Application Introduction
- 5.1.1 Adult Formula
- 5.1.2 Infant Formula
- 5.2 Global Formula DHA Sales by Application
- 5.2.1 Global Formula DHA Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Formula DHA Sales by Application (2021-2032)
- 5.2.3 Global Formula DHA Sales Market Share by Application (2021-2032)
- 5.3 Global Formula DHA Revenue by Application
- 5.3.1 Global Formula DHA Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Formula DHA Revenue by Application (2021-2032)
- 5.3.3 Global Formula DHA Revenue Market Share by Application (2021-2032)
6 Global Formula DHA Sales by Region
- 6.1 Global Formula DHA Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Formula DHA Sales by Region (2021-2032)
- 6.2.1 Global Formula DHA Sales by Region (2021-2026)
- 6.2.2 Global Formula DHA Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Formula DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Formula DHA Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Formula DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Formula DHA Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Formula DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Formula DHA Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Formula DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Formula DHA Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Formula DHA Revenue by Region
- 7.1 Global Formula DHA Revenue by Region
- 7.1.1 Global Formula DHA Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Formula DHA Revenue by Region (2021-2026)
- 7.1.3 Global Formula DHA Revenue by Region (2027-2032)
- 7.1.4 Global Formula DHA Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Formula DHA Revenue (2021-2032)
- 7.2.2 North America Formula DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Formula DHA Revenue (2021-2032)
- 7.3.2 Europe Formula DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Formula DHA Revenue (2021-2032)
- 7.4.2 Asia-Pacific Formula DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Formula DHA Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Formula DHA Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DSM Formula DHA Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 Roquette
- 8.2.1 Roquette Company Information
- 8.2.2 Roquette Business Overview
- 8.2.3 Roquette Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Roquette Formula DHA Product Portfolio
- 8.2.5 Roquette Recent Developments
- 8.3 ADM
- 8.3.1 ADM Company Information
- 8.3.2 ADM Business Overview
- 8.3.3 ADM Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ADM Formula DHA Product Portfolio
- 8.3.5 ADM Recent Developments
- 8.4 Corbion
- 8.4.1 Corbion Company Information
- 8.4.2 Corbion Business Overview
- 8.4.3 Corbion Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Corbion Formula DHA Product Portfolio
- 8.4.5 Corbion Recent Developments
- 8.5 Lonza Group
- 8.5.1 Lonza Group Company Information
- 8.5.2 Lonza Group Business Overview
- 8.5.3 Lonza Group Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Lonza Group Formula DHA Product Portfolio
- 8.5.5 Lonza Group Recent Developments
- 8.6 CABIO
- 8.6.1 CABIO Company Information
- 8.6.2 CABIO Business Overview
- 8.6.3 CABIO Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CABIO Formula DHA Product Portfolio
- 8.6.5 CABIO Recent Developments
- 8.7 Fuxing
- 8.7.1 Fuxing Company Information
- 8.7.2 Fuxing Business Overview
- 8.7.3 Fuxing Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Fuxing Formula DHA Product Portfolio
- 8.7.5 Fuxing Recent Developments
- 8.8 Runke
- 8.8.1 Runke Company Information
- 8.8.2 Runke Business Overview
- 8.8.3 Runke Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Runke Formula DHA Product Portfolio
- 8.8.5 Runke Recent Developments
- 8.9 Cellana
- 8.9.1 Cellana Company Information
- 8.9.2 Cellana Business Overview
- 8.9.3 Cellana Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cellana Formula DHA Product Portfolio
- 8.9.5 Cellana Recent Developments
- 8.10 JC Biotech
- 8.10.1 JC Biotech Company Information
- 8.10.2 JC Biotech Business Overview
- 8.10.3 JC Biotech Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 JC Biotech Formula DHA Product Portfolio
- 8.10.5 JC Biotech Recent Developments
- 8.11 Yuexiang
- 8.11.1 Yuexiang Company Information
- 8.11.2 Yuexiang Business Overview
- 8.11.3 Yuexiang Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Yuexiang Formula DHA Product Portfolio
- 8.11.5 Yuexiang Recent Developments
- 8.12 FEMICO
- 8.12.1 FEMICO Company Information
- 8.12.2 FEMICO Business Overview
- 8.12.3 FEMICO Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 FEMICO Formula DHA Product Portfolio
- 8.12.5 FEMICO Recent Developments
- 8.13 Huison
- 8.13.1 Huison Company Information
- 8.13.2 Huison Business Overview
- 8.13.3 Huison Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Huison Formula DHA Product Portfolio
- 8.13.5 Huison Recent Developments
- 8.14 Qingdao Keyuan
- 8.14.1 Qingdao Keyuan Company Information
- 8.14.2 Qingdao Keyuan Business Overview
- 8.14.3 Qingdao Keyuan Formula DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Qingdao Keyuan Formula DHA Product Portfolio
- 8.14.5 Qingdao Keyuan Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Formula DHA Value Chain Analysis
- 9.1.1 Formula DHA Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Formula DHA Production Mode & Process
- 9.2 Formula DHA Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Formula DHA Distributors
- 9.2.3 Formula DHA Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst